OCBCO
IMCR icon

Oversea-Chinese Banking Corp (OCBC)’s Immunocore IMCR Stock Holding History

Oversea-Chinese Banking Corp (OCBC)’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,403
Closed -$308K – 347
2022
Q4 		$308K Buy
+5,403
New +$304K 0.02% 278

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Oversea-Chinese Banking Corp (OCBC)'s IMCR Position: Q1 2023 in Review

Oversea-Chinese Banking Corp (OCBC) sold out of Immunocore (IMCR) in Q1 2023, closing a stake of 5,403 shares — an estimated $308K sold.

Oversea-Chinese Banking Corp (OCBC) first reported a position in IMCR in Q4 2022 and held it in 1 quarter. The position peaked at $308K in Q4 2022. 109 funds tracked by Wall St. Rank hold IMCR as of Q1 2023.

  • Oversea-Chinese Banking Corp (OCBC) reported no remaining Immunocore position as of Q1 2023 after selling out during the quarter.
  • Oversea-Chinese Banking Corp (OCBC) sold 5,403 Immunocore shares in Q1 2023, an estimated $308K.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in Immunocore in Q4 2022 and held it in 1 quarter.
  • Oversea-Chinese Banking Corp (OCBC)'s Immunocore position peaked at $308K in Q4 2022.
  • 109 funds tracked by Wall St. Rank held Immunocore as of Q1 2023.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q1 2023, filed 4 May 2023.